Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org
| Episode | Date |
|---|---|
|
Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
|
Dec 17, 2025 |
|
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
|
Oct 17, 2025 |
|
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
|
Oct 17, 2025 |
|
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
|
Oct 16, 2025 |
|
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
|
Oct 15, 2025 |
|
Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
|
Oct 15, 2025 |
|
Evaluation of Cognition and Cognitive Disorder
|
Oct 15, 2025 |
|
Pathology and Diagnostic Frameworks for Alzheimer Disease
|
Oct 15, 2025 |